Inflammatory response in a rat model of gastroschisis is associated with an increase of NF-kappaB

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 2, 2010, Pages 160-165

  Sbragia, L ^a   Schmidt, A F ^a   Moraes, S ^a   Bittencourt, D G ^a   Goncalves F L L ^a   Pereira, L A V D ^a   Velloso, L A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Gastroschisis; Inflammation; Inflammatory mediators; Nuclear factor kappaB

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AMNION FLUID; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; FEMALE; GASTROSCHISIS; GESTATIONAL AGE; HYSTEROTOMY; IMMUNOPRECIPITATION; INFLAMMATION; INTESTINE; INTESTINE WEIGHT; LIVER; LIVER WEIGHT; NONHUMAN; ORGAN SIZE; ORGAN WEIGHT; RAT; SIGNAL TRANSDUCTION; UMBILICUS;

RATTUS;

EID: 76649098820     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010005000005     Document Type: Article

References (28)

1. Loane M, Dolk H, Bradbury I. Increasing prevalence of gastroschisis in Europe 1980-2002: a phenomenon restricted to younger mothers? Paediatr Perinat Epidemiol 2007; 21: 363-369.
2. Suita S, Okamatsu T, Yamamoto T, Handa N, Nirasawa Y, Watanabe Y, et al. Changing profile of abdominal wall defects in Japan: results of a national survey. J Pediatr Surg 2000; 35: 66-71.
3. Eggink BH, Richardson CJ, Malloy MH, Angel CA. Outcome of gastroschisis: a 20-year case review of infants with gastroschisis born in Galveston, Texas. J Pediatr Surg 2006; 41: 1103-1108.
4. Langer JC, Longaker MT, Crombleholme TM, Bond SJ, Finkbeiner WE, Rudolph CA, et al. Etiology of intestinal damage in gastroschisis. I: Effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg 1989; 24: 992-997.
5. Srinathan SK, Langer JC, Blennerhassett MG, Harrison MR, Pelletier GJ, Lagunoff D. Etiology of intestinal damage in gastroschisis. III: Morphometric analysis of the smooth muscle and submucosa. J Pediatr Surg 1995; 30: 379-383.
6. Tibboel D, Vermey-Keers C, Kluck P, Gaillard JL, Koppenberg J, Molenaar JC. The natural history of gastroschisis during fetal life: development of the fibrous coating on the bowel loops. Teratology 1986; 33: 267-272.
7. Amoury RA, Beatty EC, Wood WG, Holder TM, Ashcraft KW, Sharp RJ, et al. Histology of the intestine in human gastroschisis - relationship to intestinal malfunction: dissolution of the "peel" and its ultrastructural characteristics. J Pediatr Surg 1988; 23: 950-956.
8. Saleh AA, Isada NB, Johnson MP, Sokol RJ, Dombrowski MP, Evans MI. Amniotic fluid acetylcholinesterase is found in gastroschisis but not omphalocele. Fetal Diagn Ther 1993; 8: 168-170.
9. Bealer JF, Graf J, Bruch SW, Adzick NS, Harrison MR. Gastroschisis increases small bowel nitric oxide synthase activity. J Pediatr Surg 1996; 31: 1043-1045.
10. Guibourdenche J, Berrebi D, Vuillard E, de Lagausie P, Aigrain Y, Oury JF, et al. Biochemical investigations of bowel inflammation in gastroschisis. Pediatr Res 2006; 60: 565-568.
11. Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, Matsumoto H, et al. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology 1999; 30: 934-943.
12. Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996; 87: 13-20.
13. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
14. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998; 101: 802-811.
15. Correia-Pinto J, Tavares ML, Baptista MJ, Estevao-Costa J, Flake AW, Leite-Moreira AF. A new fetal rat model of gastroschisis: development and early characterization. J Pediatr Surg 2001; 36: 213-216.
16. Snyder CL. Outcome analysis for gastroschisis. J Pediatr Surg 1999; 34: 1253-1256.
17. Driver CP, Bruce J, Bianchi A, Doig CM, Dickson AP, Bowen J. The contemporary outcome of gastroschisis. J Pediatr Surg 2000; 35: 1719-1723.
18. Oldham KT, Coran AG, Drongowski RA, Baker PJ, Wesley JR, Polley TZ Jr. The development of necrotizing enterocolitis following repair of gastroschisis: a surprisingly high incidence. J Pediatr Surg 1988; 23: 945-949.
19. Dilsiz A, Gundogan AH, Aktan M, Duman S, Aktug T. Nitric oxide synthase inhibition prevents intestinal damage in gastroschisis: a morphological evaluation in chick embryos. J Pediatr Surg 1999; 34: 1248-1252.
20. Wigglesworth JS. Experimental growth retardation in the foetal rat. J Pathol Bacteriol 1964; 88: 1-13.
21. Franchi-Teixeira AR, Weber Guimaraes BM, Nogueira B, Bittencourt D, Violin L, Sbragia L. Aminiotic fluid and intra-uterine growth restriction in a gastroschisis fetal rat model. Fetal Diagn Ther 2005; 20: 494-497.
22. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-445.
23. Atreya I, Atreya R, Neurath MF. NF-kappaB in inflammatory bowel disease. J Intern Med 2008; 263: 591-596.
24. Halpern MD, Khailova L, Molla-Hosseini D, Arganbright K, Reynolds C, Yajima M, et al. Decreased development of necrotizing enterocolitis in IL-18-deficient mice. Am J Physiol Gastrointest Liver Physiol 2008; 294: G20-G26.
25. De Plaen IG, Liu SX, Tian R, Neequaye I, May MJ, Han XB, et al. Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 2007; 61: 716-721.
26. Halpern MD, Holubec H, Dominguez JA, Meza YG, Williams CS, Ruth MC, et al. Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2003; 284: G695-G702.
27. Bolke E, Jehle PM, Trautmann M, Gotz I, Krebs B, Steinbach G, et al. Different acute-phase response in newborns and infants undergoing surgery. Pediatr Res 2002; 51: 333-338.
28. Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, Ward CW, et al. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol 2004; 18: 2502-2512.